LES Foundation | LESI | Print Page | Contact Us | Sign In | Join
Changes to Biopharma's External Ecosystem That Will Bring Permanent Changes to the Biopharmaceutical
Tell a Friend About This EventTell a Friend
 

LES New Jersey Chapter Meeting

4/30/2015
When: Thursday, April 30, 2015
6:00 PM – 9:00 PM
Where: Dolce Basking Ridge
300 N. Maple Ave
Basking Ridge, New Jersey 
United States

« Go to Upcoming Event List  

DATE & TIME
Thursday, April 30, 2015
6:00 PM – 9:00 PM

LOCATION
Dolce Basking Ridge
300 N. Maple Ave
Basking Ridge, NJ
http://www.baskingridge.dolce.com

TITLE
Changes to Biopharma's External Ecosystem That Will Bring Permanent Changes to the Biopharmaceutical Industry

SPEAKER
Ed Saltzman, President & Founder, Defined Health

DESCRIPTION
There are numerous important factors within the biopharmaceutical industry that have a vital impact on the success of companies and their products. However, we are also facing some momentous changes in the external environment. Some of these will be game changers for the biopharma industry because they will result in permanent disruption to the ecosystem in which the industry operates.

The LES-NJ Chapter welcomes Ed Saltzman of Defined Health back to the podium, a favorite speaker of LES members. After many years of evaluating the opportunity space, Defined Health has begun to weigh the impact more heavily that the industry’s operating environment will have on a product’s success or lack thereof, including pricing and reimbursement models and an expanding list of stakeholders with a say in therapeutic decisions.

In this talk he will address the most disruptive external factors, both market forces as well as scientific advances that have the biggest potential to seriously change the biopharma industry’s future, and discuss the weight and the timing of the impact of each of these. Among these:

  • The influence of governments’ and private payers’ ability to afford new innovative therapies and resulting changes in pricing and payment system models, especially in the US
  • Continued progress in gene therapy and regenerative medicine

Ed’s company, Defined Health, is a business development strategy consultancy to the life sciences. Defined Health advises senior industry executives on business development and disease area strategy. Prior to founding Defined Health, Mr. Saltzman held positions at the Ayerst Laboratories unit of American Home Products and at FIND/SVP.

COST AND CANCELLATION POLICY
$60 LES Members in advance (received by 12:00 Midnight EST, Tuesday, April 28th)
$70 Non-Members in advance (received by 12:00 Midnight EST, Tuesday, April 28th)

$70 LES Members at the door (cash and checks only)
$80 Non-Members at the door (cash and checks only)

Cancellations made after 12:00 Midnight EST, Tuesday, April 28th cannot be reimbursed, but substitutions are welcome! 

SCHEDULE 
Cocktail Reception - 6:00pm - 7:30 (Includes Full Service Open Bar, Passed Hors d'oeuvres, 3 Food Stations)
Program - 7:30pm - 9:00 (Coffee & Dessert)
Dress Code:  Business or Business Casual

Questions?
LES-NJ Chapter Chair, Linda Webb (973) 292-5001 Ext. 232
LES-NJ Chapter Co-Chair, Lori Waldron (973) 643-5158
LES-NJ Chapter Co-Chair, Daisy Rivera-Muzzio (973) 903-1809

SPEAKER BIO
Ed Saltzman, President and Founder, Defined Health
Ed is President of Defined Health, a leading business development strategy consultancy to the life sciences.  Ed advises senior industry executives on business development and disease area strategy.

Prior to founding Defined Health, Ed held positions at the Ayerst Laboratories unit of American Home Products and at FIND/SVP.

Ed is a well regarded and in demand speaker on industry issues.  He has addressed hundreds of industry audiences over the past 20 years.  In addition, Ed regularly presents targeted strategy briefings and conducts discussions privately with scores of boards of directors, executive management committees and licensing and business development groups at large pharma, specialty pharma and biotech companies. 

Ed is a member of the Licensing Executives Society and the New York Pharma Forum and is a graduate of New York University.